Condition

Acute Respiratory Distress Syndrome (1)

COVID-19 (1)

Dengue Fever (1)

Lung Diseases (1)

Respiratory Distress Syndrome, Adult (1)

Overall Status

Withdrawn (2)

Recruiting (1)

Terminated (1)

Phase

phase 2 (4)

Sponsor

Implicit Bioscience (2)

QuantumLeap Healthcare Collaborative (1)

University of Washington (1)

Intervention

ic14 (4)

placebo (2)

aviptadil acetate (1)

celecoxib famotidine (1)

cyclosporine (1)

narsoplimab (1)

pulmozyme (1)

remdesivir (1)

Study Documents

Intervention Type

drug (4)

biological (1)

other (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

ic14

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

Recruiting

COVID-19

Remdesivir
+6 more

Birmingham, Alabama
+18 more

Jul 19, 2021

Dengue Fever Trial (IC14, Placebo)

Withdrawn

Dengue Fever

IC14
Placebo

(no location specified)

Mar 12, 2019

Acute Respiratory Distress Syndrome Trial (IC14, Placebo)

Withdrawn

Acute Respiratory Distress Syndrome

IC14
Placebo

(no location specified)

Mar 12, 2019

Respiratory Distress Syndrome, Adult, Lung Diseases Trial in Seattle (IC14)

Terminated

Respiratory Distress Syndrome, Adult
Lung Diseases

IC14

Seattle, Washington

University of Washington

May 12, 2017